Skip to content
10-K

Annual Report

TYRA BIOSCIENCES, INC. TYRA

0000950170-25-046124

← back to feed
Filed
Mar 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 25, 2025 53.09M sh
Shares Diluted FY 2024 · Dec 31, 2023 42.7M sh
Capex FY 2024 · Dec 31, 2023 $770K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$50.14M
Cash And Equivalents FY 2024 · Dec 31, 2023 $58.01M
Current Liabilities FY 2024 · Dec 31, 2023 $15.33M
Total Liabilities FY 2024 · Dec 31, 2023 $21.6M
Current Assets FY 2024 · Dec 31, 2023 $211.67M
Total Assets FY 2024 · Dec 31, 2023 $225.86M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.62
Eps Basic FY 2024 · Dec 31, 2023 −$1.62
Rd Expense FY 2024 · Dec 31, 2023 $62.52M
Net Income FY 2024 · Dec 31, 2023 −$69.13M
Operating Income FY 2024 · Dec 31, 2023 −$79.95M
Stockholders Equity FY 2024 · Dec 31, 2022 $257.83M